Institutional shares held 292 Million
1.39M calls
910K puts
Total value of holdings $115B
$543M calls
$357M puts
Market Cap $148B
378,320,992 Shares Out.
Institutional ownership 77.21%
# of Institutions 2,488


Latest Institutional Activity in SYK

Top Purchases

Q2 2025
Alecta Tjanstepension Omsesidigt Shares Held: 458K ($180M)
Q2 2025
Family Legacy Financial Solutions, LLC Shares Held: 10.9K ($4.29M)
Q2 2025
Swedbank Ab Shares Held: 120K ($47M)
Q2 2025
Czech National Bank Shares Held: 84.1K ($33M)
Q2 2025
Ifm Investors Pty LTD Shares Held: 69.5K ($27.2M)

Top Sells

Q2 2025
Livforsakringsbolaget Skandia, Omsesidigt Shares Held: 15.1K ($5.91M)
Q2 2025
Diversified Trust CO Shares Held: 8.55K ($3.35M)
Q2 2025
Northstar Advisory Group, LLC Shares Held: 4.34K ($1.7M)
Q2 2025
Confluence Investment Management LLC Shares Held: 233K ($91.2M)
Q2 2025
Carderock Capital Management Inc Shares Held: 19.3K ($7.56M)

About SYK

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.


Insider Transactions at SYK

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
325K Shares
From 30 Insiders
Grant, award, or other acquisition 110K shares
Exercise of conversion of derivative security 214K shares
Bona fide gift 198 shares
Sell / Disposition
1.95M Shares
From 22 Insiders
Payment of exercise price or tax liability 177K shares
Bona fide gift 864K shares
Open market or private sale 913K shares

Track Institutional and Insider Activities on SYK

Follow STRYKER CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYK shares.

Notify only if

Insider Trading

Get notified when an Stryker Corp insider buys or sells SYK shares.

Notify only if

News

Receive news related to STRYKER CORP

Track Activities on SYK